DIANA WHITE: Open Payments
NPI 1154920668 · SAN ANTONIO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,019 in 63 payments from 13 companies in 2025. Trend: 2023 $2,316 · 2024 $2,245 · 2025 $3,019
Food & beverage: $2,645Travel & lodging: $374
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 10 | $723 |
| Abbott Laboratories | 8 | $632 |
| Novo Nordisk Inc | 6 | $454 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $394 |
| Novartis Pharmaceuticals Corporation | 19 | $350 |
| Boston Scientific Corporation | 1 | $127 |
| AstraZeneca Pharmaceuticals LP | 2 | $109 |
| PFIZER INC. | 4 | $68 |
| Esperion Therapeutics, Inc. | 3 | $53 |
| Merck Sharp & Dohme LLC | 3 | $53 |
Products named: REPATHA, CARDIOMEMS, Kerendia, LEQVIO, Wegovy, BodyGuardian, Ozempic, AIRSUPRA.
Industry payments across TX — which companies pay providers there.
